Sara J. Buhrlage

5.5k citations
66 papers · 2.9k indexed · 2 hit papers · h-index 26
Topics
Ubiquitin and proteasome pathways (21 papers)Protein Degradation and Inhibitors (14 papers)Chronic Lymphocytic Leukemia Research (13 papers)

In The Last Decade

Sara J. Buhrlage

60 papers receiving 2.9k citations

Hit Papers

Developing Irreversible Inhibitors of the Protein Kinase ...201320262017202120132022100200300400500

Peers

Sara J. Buhrlage
Comparison fields: 5 of 108
  • Molecular Biology 1.9k
  • Oncology 717
  • Organic Chemistry 440
  • Genetics 437
  • Immunology 429
Replace Min H. Kang with:
Min H. Kang United States
Monica Schenone United States
Steven G. Nadler United States
Mark F. van Delft Australia
Steffan T. Nawrocki United States
Xiaoyun Lu China
Dayong Zhai United States
Kantharaj Ethirajulu Singapore
Cai‐Hong Yun China
Lisa Wiesmüller Germany
Sara J. Buhrlage relative to Min H. Kang United States Min H. Kang's profile →
Citations per field
00.5×
Min H. Kang · 1×
Citations per year

Countries citing papers authored by Sara J. Buhrlage

Since Specialization
Citations

This map shows the geographic impact of Sara J. Buhrlage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara J. Buhrlage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara J. Buhrlage more than expected).

Fields of papers citing papers by Sara J. Buhrlage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara J. Buhrlage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara J. Buhrlage. The network helps show where Sara J. Buhrlage may publish in the future.

Co-authorship network of co-authors of Sara J. Buhrlage

This figure shows the co-authorship network connecting the top 25 collaborators of Sara J. Buhrlage. A scholar is included among the top collaborators of Sara J. Buhrlage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara J. Buhrlage. Sara J. Buhrlage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 9
5 3
6 26
7 19
8 21
9 4
10 19
11 26
12 1
13 46
14 137
15 115
16 35
17 259
18 138
19
Developing Irreversible Inhibitors of the Protein Kinase Cysteinomebreakdown →
513
20 36

About Sara J. Buhrlage

Sara J. Buhrlage is a scholar working on Genetics, Hematology and Oncology, having authored 66 papers that have together received 2.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (21 papers), Protein Degradation and Inhibitors (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). The work is most often cited by research in Genetics (437 citations), Molecular Biology (1.9k citations) and Oncology (717 citations). Sara J. Buhrlage has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Nathanael S. Gray, Qingsong Liu, Tinghu Zhang, Zheng Zhao, Yogesh Sabnis, Lyn H. Jones, Xiaoxi Liu, Nathan J. Schauer, Robert S. Magin and Laura M. Doherty. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026